Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1999 1
2001 4
2002 16
2003 15
2004 18
2005 20
2006 20
2007 16
2008 18
2009 20
2010 14
2011 16
2012 18
2013 16
2014 12
2015 14
2016 14
2017 11
2018 10
2019 5
2020 9
2021 8
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

278 results

Results by year

Filters applied: . Clear all
Page 1
Tony W. Keller (1937-2023).
Laukien FH, Banci L, Meier BH, Kessler H, Griesinger C. Laukien FH, et al. Among authors: kessler h. Angew Chem Int Ed Engl. 2023 Dec 21;62(52):e202316747. doi: 10.1002/anie.202316747. Epub 2023 Nov 23. Angew Chem Int Ed Engl. 2023. PMID: 37997554
Improving oral bioavailability of cyclic peptides by N-methylation.
Räder AFB, Reichart F, Weinmüller M, Kessler H. Räder AFB, et al. Among authors: kessler h. Bioorg Med Chem. 2018 Jun 1;26(10):2766-2773. doi: 10.1016/j.bmc.2017.08.031. Epub 2017 Aug 31. Bioorg Med Chem. 2018. PMID: 28886995 Free article. Review.
Orally Active Peptides: Is There a Magic Bullet?
Räder AFB, Weinmüller M, Reichart F, Schumacher-Klinger A, Merzbach S, Gilon C, Hoffman A, Kessler H. Räder AFB, et al. Among authors: kessler h. Angew Chem Int Ed Engl. 2018 Oct 26;57(44):14414-14438. doi: 10.1002/anie.201807298. Epub 2018 Oct 3. Angew Chem Int Ed Engl. 2018. PMID: 30144240 Review.
αvβ3- or α5β1-Integrin-Selective Peptidomimetics for Surface Coating.
Mas-Moruno C, Fraioli R, Rechenmacher F, Neubauer S, Kapp TG, Kessler H. Mas-Moruno C, et al. Among authors: kessler h. Angew Chem Int Ed Engl. 2016 Jun 13;55(25):7048-67. doi: 10.1002/anie.201509782. Epub 2016 Jun 3. Angew Chem Int Ed Engl. 2016. PMID: 27258759 Review.
Tumor Targeting via Integrin Ligands.
Marelli UK, Rechenmacher F, Sobahi TR, Mas-Moruno C, Kessler H. Marelli UK, et al. Among authors: kessler h. Front Oncol. 2013 Aug 30;3:222. doi: 10.3389/fonc.2013.00222. Front Oncol. 2013. PMID: 24010121 Free PMC article. Review.
NMR-based screening technologies.
Coles M, Heller M, Kessler H. Coles M, et al. Among authors: kessler h. Drug Discov Today. 2003 Sep 1;8(17):803-10. doi: 10.1016/s1359-6446(03)02796-x. Drug Discov Today. 2003. PMID: 12946643 Review.
Exploring the Role of RGD-Recognizing Integrins in Cancer.
Nieberler M, Reuning U, Reichart F, Notni J, Wester HJ, Schwaiger M, Weinmüller M, Räder A, Steiger K, Kessler H. Nieberler M, et al. Among authors: kessler h. Cancers (Basel). 2017 Sep 4;9(9):116. doi: 10.3390/cancers9090116. Cancers (Basel). 2017. PMID: 28869579 Free PMC article. Review.
Therapeutic Radiopharmaceuticals Targeting Integrin αvβ6.
Färber SF, Wurzer A, Reichart F, Beck R, Kessler H, Wester HJ, Notni J. Färber SF, et al. Among authors: kessler h. ACS Omega. 2018 Feb 28;3(2):2428-2436. doi: 10.1021/acsomega.8b00035. ACS Omega. 2018. PMID: 30023833 Free PMC article.
Integrin modulators: a patent review.
Kapp TG, Rechenmacher F, Sobahi TR, Kessler H. Kapp TG, et al. Among authors: kessler h. Expert Opin Ther Pat. 2013 Oct;23(10):1273-95. doi: 10.1517/13543776.2013.818133. Expert Opin Ther Pat. 2013. PMID: 24050747 Review.
Protein folding by interaction.
Buchner J, Kessler H. Buchner J, et al. Among authors: kessler h. Structure. 2014 Jul 8;22(7):936-7. doi: 10.1016/j.str.2014.06.006. Structure. 2014. PMID: 25007223 Free article.
278 results